Research Article
Volume 3 Issue 11 - 2020
Goldberg Shprintzen Syndrome: A Novel Therapeutic Approach
Aamir Jalal Al Mosawi1,2*
1Advisor in Pediatrics and Pediatric Psychiatry, Children Teaching Hospital of Baghdad Medical City, Baghdad, Iraq
2Head, Iraq Headquarter of Copernicus Scientists International Panel, Baghdad, Iraq
*Corresponding Author: Aamir Jalal Al Mosawi, Advisor in Pediatrics and Pediatric Psychiatry, Children Teaching Hospital of Baghdad Medical City and Head, Iraq Headquarter of Copernicus Scientists International Panel, Baghdad, Iraq.
Received: September 16, 2020; Published: October 31, 2020


Background: Goldberg Shprintzen syndrome is a very rare autosomal recessive syndrome associated with mental retardation, a distinctive facial abnormalities, Hirschsprung disease and neurological abnormalities. In a previous publication, we described the occurrence of the thirty fourth and thirty fifth cases of the syndrome in two Iraqi brothers. There are no known therapies that are associated with improvement in the neurologic disability and mental retardation in Goldberg Shprintzen syndrome. The aim of this paper is to describe the successful treatment of one of the Iraqi brothers with a novel therapeutic approach.

Patients and Methods: The younger brother was treated with aim of improving neurological abnormalities which included spasticity and inability to walk without support and also to improve mental disabilities which included poor cognitive abilities, and the lack of speech development. The younger brother was treated with an evidence-based therapeutic approach based on our extensive experiences with treatment of brain damage and mental retardation.

Results: After about six months, the older brother who received only nutritional support and muscle relaxants showed slight improvement in spasticity and general health, but he didn’t experience any improvement in motor and mental-cognitive disabilities, and he remained unable to stand and didn’t show any evidence of speech development. Treatment of the younger was associated with significant improvement in cognitive abilities and his speech development was initiated and improved. He was able to walk alone, and his fine motor skills showed marked improvement and was able to drink from cup and feed himself with as spoon. He was trying to copy a line and a circle. Treatment was not associated with any side effects.

Conclusion: There are very limited experiences with treatment of very rare disorders like Goldberg-Shprintzen syndrome. However, we have shown in this research paper that the use of evidence-based multi-factorial therapies was very beneficial in this condition.

Keywords: Goldberg-Shprintzen Syndrome; Novel Therapies


  1. Al-Mosawi AJ. “The Thirty Fourth and Thirty Fifth Cases of Goldberg Shprintzen Syndrome”. Journal of Clinical Research and Reports 1 (2020): 1-4.
  2. Al-Mosawi AJ. “New Therapies for the treatment of spastic cerebral palsy”. Medical Journal of Clinical Trials and Case Studies2 (2019): 1-9.
  3. Al-Mosawi AJ. “The pattern of cerebral palsy in Iraqi children”. MedLife Clinics1 (2019): 1-9.
  4. Al-Mosawi AJ. “The novel use of cerebrolysin and citicoline in the treatment of kernicterus”. Online Journal of Neurology and Brain Disorders1 (2019): 208-212.
  5. Al-Mosawi AJ. “The Use of Intramuscular Cerebrolysin and Citicoline in the Treatment of Kernicterus”. SunKrist Journal of Neonatology and Pediatrics1 (2019): 1-5.
  6. Al-Mosawi AJ. “New Therapies for the treatment of ataxic cerebral palsy caused by kernicterus”. EC Clinical and Medical Case Reports4 (2020): 26-31.
  7. Al-Mosawi AJ. “A Unique experience with mental and developmental retardation: Innovative Medical therapies for idiopathic mental retardation”. EC Clinical and Medical Case Reports5 (2020): 42-54.
  8. Al-Mosawi AJ. “The Treatment of a Child with Birth Asphyxia Induced Brain Atrophy, Adrenal Hemorrhage, and Bi-lateral Hyperoxaluric Nephrocalcinosis: A Challenging Case and a Unique Experience”. Open Access Journal of Biogeneric Science and Research2 (2020): 1-6.
  9. Al-Mosawi AJ. “The experience with the use of nandrolone decanoate and pyritinol in children with cerebral palsy”. Open Access Journal of Biogeneric Science and Research3 (2020): 1-3.
  10. Al-Mosawi AJ. “Treatment of A Boy with Idiopathic Mental Retardation: From Uneducable to Educable”. Progressing Aspects in Pediatrics and Neonatology5 (2020): 197-202.
  11. Al-Mosawi AJ. “Cerebral palsy: A unique illustrated experience”. Medico Research Chronicles4 (2020): 2017-239.
  12. Al-Mosawi AJ. “Citicoline research progress”. 1st edition., Saarbrücken; LAP Lambert Academic Publishing (2019).
  13. Al-Mosawi AJ. “The Use of Citicoline in Pediatric Neurology and Pediatric Psychiatry”. Austin Pediatrics1 (2019): 1071-1072.
  14. Al-Mosawi AJ. “Cure of Autistic Disorders: Mission Impossible is Possible in an Illustrated Pioneering Experience”. Archives of Health Science (2020).
  15. Al-Mosawi AJ. “Cure of autistic disorders: Our unique experience”.1st edition., Saarbrücken; LAP Lambert Academic Publishing (2020).
  16. Al-Mosawi AJ. “Cura dei disturbi autistici: La nostra esperienza unica: Medicina basata sull'evidenza (Italian Edition).Edizioni Sapienza (2020).
  17. Al-Mosawi AJ. “Guérison des troubles autistiques : Notre expérience unique: La médecine factuelle (French Edition).Editions Notre Savoir (2020).
  18. Al-Mosawi AJ. “New therapies for Rett syndrome”. Journal of Bio Innovation3 (2019): 301-307.
  19. Al-Mosawi AJ. “Clinical uses of Cerebrolysin in Pediatric Neuropsychiatry”. Science World Journal of Pharmaceutical Sciences1 (2020): 1-4.
  20. Al-Mosawi AJ. “New medical therapies for the treatment of myelomeningocele”. Surgical Medicine Open Access Journal4 (2019): 1-4.
  21. Al-Mosawi AJ. “A novel therapy for pediatric juvenile spinal muscular atrophy”. 1st edition., Saarbrücken; LAP Lambert Academic (2018).
  22. Al-Mosawi AJ. “The use of cerebrolysin in pediatric Wohlfart Kugelberg Welander syndrome”. MOJ Clinical and Medical Case Reports1 (2020): 20-23.
  23. Al-Mosawi AJ. “A novel therapy for pediatric Charcot Marie Tooth disease”. 1st edition., Saarbrücken; LAP Lambert Academic Publishing (2018).
  24. Al-Mosawi AJ. “The use of Cerebrolysin in Pediatric Charcot Marie Tooth Disease”. Journal of Neurological Research and Therapy2 (2020): 17-21.
  25. Al-Mosawi AJ. “Agenesis of corpus callosum with colpocephaly: A novel therapy”. 1st edition., Saarbrücken; LAP Lambert Academic Publishing (2019).
  26. Al-Mosawi AJ. “The use of piracetam and cerebrolysin in the treatment of agenesis of corpus callosum with colpocephaly”. EC Clinical and Medical Case Reports1 (2020): 01-05.
  27. Al-Mosawi AJ. “Recent Uses of Piracetam in Pediatric Neurology”. SunKrist Neurology, Neurosurgery and Stroke Journal 1 (2020): 1002.
  28. Al-Mosawi AJ. “Dramatic effect of nandrolone decanoate on motor development in cerebral palsy. Second Congress of the European Academy of Paediatric Societies EAPS 2008, Nice, France 24-28 October”. Archives of Disease in Childhood 11 (2008).
  29. Al-Mosawi AJ. “Experience with refractory vitamin D-resistant rickets and non-17α alkyl testosterone derivative anabolic agent”. Therapy 1 (2005): 91-94.
  30. Al-Mosawi AJ. “Dramatic effect of non-17 alpha alkyl testosterone derivative anabolic agent on growth in a child with achondroplasia on the short term”. Therapy (2006).
Citation: Aamir Jalal Al Mosawi.,et al. “Goldberg Shprintzen Syndrome: A Novel Therapeutic Approach”. EC Clinical and Medical Case Reports 3.11 (2020): 115-123.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

July Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the July issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before July 15, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.